USD/JPY could be sold on strength

It has been a relatively quiet start to the week for the major FX pairs with little change in sentiment from the weekend.  


Perhaps the most significant development is the fact USD/JPY has slipped below Friday’s lows, with a new low of 101.26 being printed. The only notable release out of Japan was the industrial production reading which came in slightly below estimates at +0.5%, but still showed an improvement from the previous month.

Recent releases out of Japan have been underwhelming to say the least and we are likely to continue seeing this situation unravel in the near term. Japan’s Tankan report this week is likely to have an impact on how the yen trades this week and warrants caution. It’s also a big week on the US dollar side of the equation with the all-important non-farm payrolls due out. Investors will be hoping to see strong US data which would lift the greenback and ultimately aid a USD/JPY recovery.

The 101.50 level is key

Key support at 101.50 was broken on Friday and has since turned into resistance. This level was retested on Friday and resulted in further selling, with 101.50 capping gains. The next support is at the 101 whole number, but this might not matter if there are no catalysts to trigger a recovery.

Currently the picture looks quite bearish but I would still be against a momentum play. My preference would be to sell the pair on rallies back towards the 101.50 region. This presents the best value and could really pay off if the losses accelerate. Should geopolitical risk ramp up then this could be a source of further yen strength which would also be a negative for the pair.

Denne informasjonen er utarbeidet av IG, forretningsnavnet til IG Markets Limited. I tillegg til disclaimeren nedenfor, inneholder ikke denne siden oversikt over kurser, eller tilbud om, eller oppfordring til, en transaksjon i noe finansielt instrument. IG påtar seg intet ansvar for handlinger basert på disse kommentarene og for eventuelle konsekvenser som et resultat av dette. Ingen garanti gis for nøyaktigheten eller fullstendigheten av denne informasjonen. Personer som handler ut i fra denne informasjonen gjør det på egen risiko. Forskning gitt her tar ikke hensyn til spesifikke investeringsmål, finansiell situasjon og behov som angår den enkelte person som mottar dette. Denne informasjonen er ikke utarbeidet i samsvar med regelverket for investeringsanalyser, så derfor er denne informasjonen ansett å være markedsføringsmateriale. Selv om vi ikke er hindret i å handle i forkant av våre anbefalinger, ønsker vi ikke å dra nytte av dem før de blir levert til våre kunder. Se fullstendig disclaimer og kvartalsvis oppsummering.